Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
04/2005
04/14/2005WO2003090678A3 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
04/14/2005US20050080135 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
04/14/2005CA2541303A1 Process of preparing o-carbamoyl compounds in the presence of active amine group
04/13/2005EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
04/13/2005EP0897988B1 Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
04/13/2005CN1605585A Process for making theanine and theanine food and drink with high nutrition
04/12/2005US6878829 Reacting amino ester with cyanoacetic ester to give cyanoacetamide, catalytic hydrogenation
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/07/2005WO2005030780A1 Fluorescent labeled sphingosines
04/07/2005WO2005030706A1 Amide type carboxamide derivative
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030703A1 PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE α2δ- PROTEIN
04/07/2005WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use
04/07/2005WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use
04/07/2005WO2004091513A3 9-aminomethyl substituted minocycline compounds
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases
04/07/2005CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/06/2005CN1603305A Process for synthesis of L-beta-asparagine
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/06/2005CN1195737C HIV proteinase inhibitor
04/05/2005US6875887 Process for the preparation of iopamidol
04/05/2005US6875760 Glucagon antagonists/inverse agonists
03/2005
03/31/2005WO2005028422A1 Abiotic heparin antagonists
03/31/2005WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor
03/31/2005US20050070483 Subunit of a calcium channel; 3-[(2-Amino-4-methyl-pentanoylamino)-methyl]-5-methyl-octanoic acid for example or corresponding 1,5-diazocane-2,6-diones; treating drug addiction, pain and various mood disorders including depression and bipolar disorder; bioavailability
03/31/2005CA2539301A1 Abiotic heparin antagonists
03/30/2005EP1517915A2 Prodrugs of excitatory amino acids
03/30/2005EP1235788B1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties
03/30/2005EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005CA2241362C Compositions and processes for treating subterranean formations
03/24/2005WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
03/24/2005WO2005025554A2 Dipeptidyl peptidase iv inhibitor
03/24/2005WO2004062588A3 Water-soluble polymeric bone-targeting drug delivery system
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/24/2005DE10341234A1 Novel N-acyl-hydroxyamino acid alkylamides with a ceramide-like structure are useful in compositions used for protection of skin or hair
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1515926A2 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
03/23/2005CN1597663A Method of synthesining isoprutuion using dionethyl amine water solution
03/23/2005CN1597662A A kind of aromatic acid amide compound its preparation method and use
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation
03/22/2005US6870065 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy-carbonyl) phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation
03/22/2005US6870026 Biodegradable chelate compounds formed by one pot amidation of anhydrides with ethanolamine, used for agricultural applications such as fertilizers
03/22/2005US6869974 Pharmaceutical compounds
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005WO2004083867A3 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester
03/17/2005US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
03/16/2005EP1513803A1 Ligands that are inhibitors of the rar receptors
03/16/2005EP1215200B1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/10/2005WO2005021525A1 Aryl piperidine amides
03/10/2005WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/10/2005WO2005021024A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054559 Compounds for sustained release of orally delivered drugs
03/10/2005CA2536461A1 Aryl piperidine amides
03/10/2005CA2510677A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
03/09/2005EP1512692A2 Novel inhibitors of prenylated pyrophosphate consuming enzymes
03/09/2005EP1511719A1 Amide derivatives as inhibitors of the enzymatic activity of renin
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005CN1590368A Recovery method of demeclocy cline hydrochloride crystal mother liquor
03/09/2005CN1192016C Process for preparation of 4-(des-dimethylamino)-tetracyclines
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864289 Insecticides
03/03/2005US20050049310 Aryl and heteroaryl compounds, compositions and methods of use
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049239 Type 2 glycine transporter inhibitors; muscle spasticity, tinnitus, epilepsy neuropathic pain, obesity
03/03/2005DE10333042A1 Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden A process for preparing cyclic phosphonic anhydrides
03/03/2005CA2536173A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
03/02/2005EP1509254A1 New agents for magnetic imaging method
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005CN1587258A Method for extracting theanine from tea
03/01/2005US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
02/2005
02/24/2005WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists
02/24/2005WO2005016867A2 Anthranilic acid derivatives and their use as activators of the hm74a receptor
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 162